Figures & data
Figure 2 Schematic representation of the mevalonate pathway and the effects of the nitrogen-containing bisphosphonate.
![Figure 2 Schematic representation of the mevalonate pathway and the effects of the nitrogen-containing bisphosphonate.](/cms/asset/6574b1e0-c19d-4909-a847-3d78cb150ba0/dcia_a_2155_f0002_c.jpg)
Figure 3 Chemical structures of estradiol and some SERMs.
![Figure 3 Chemical structures of estradiol and some SERMs.](/cms/asset/2634fb64-a983-48f4-b601-ef464e2f264b/dcia_a_2155_f0003_b.jpg)
Figure 4 The domain structure of the oestrogen receptors. The N-terminal domain with its ligand-independent activation function-1 (AF-1). The C (DNA-binding) domain mediates sequence-specific DNA binding. The D- or hinge-domain contains nuclear translocation signal and the multifunctional E/F domain, responsible for ligand binding, homo- and heterodimerization, and ligand-dependent co-factor interaction (AF-2).
![Figure 4 The domain structure of the oestrogen receptors. The N-terminal domain with its ligand-independent activation function-1 (AF-1). The C (DNA-binding) domain mediates sequence-specific DNA binding. The D- or hinge-domain contains nuclear translocation signal and the multifunctional E/F domain, responsible for ligand binding, homo- and heterodimerization, and ligand-dependent co-factor interaction (AF-2).](/cms/asset/2b391bd1-9e66-4df8-a863-d8ec4782788f/dcia_a_2155_f0004_c.jpg)